We’re very excited to share that VHLGenetics has recently expanded its capabilities with the addition of a short-read sequencer: the Aviti from Element Biosciences.
This new technology enables us to broaden our portfolio and support our partners with both whole genome sequencing and targeted sequencing. Over the past weeks, our team has been focused on validation, which we successfully completed last week. This week, we’re proud to be running our first routine projects on the Aviti.
If you’re curious about what this technology could contribute for your project, feel free to reach out — we’d be happy to share more about our Aviti sequencer and explore the possibilities together.
